Status:
WITHDRAWN
Adherence of Iron Succinylate Therapy in Pregnancy
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Pregnancy Related
Pregnancy Anemia
Eligibility:
FEMALE
18-50 years
Brief Summary
According to the World Health Organization (WHO), anemia is the most common disease, affecting \>1.5 billion people worldwide. Furthermore, iron deficiency anemia (IDA) accounts for 50% of cases of an...
Detailed Description
Measurement of serum ferritin has the highest sensitivity and specificity for diagnosis of IDA unless there is a concurrent inflammatory condition. The lower threshold value for hemoglobin (Hb) in pre...
Eligibility Criteria
Inclusion
- Pregnancy
- Anaemia
- Iron treatment before 3 months of pregnancy
- Informed Consent
- Compliant with study procedures
Exclusion
- Iron treatment after 3 months of pregnancy
Key Trial Info
Start Date :
December 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03873571
Start Date
December 30 2022
End Date
December 30 2023
Last Update
February 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iaso Hospital
Athens, Greece